Baylor College of Medicine, Department of Pediatrics, Global and Immigrant Health, Global Tuberculosis Program, Houston, Texas, United States.
Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
Euro Surveill. 2023 Oct;28(42). doi: 10.2807/1560-7917.ES.2023.28.42.2300051.
BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most from targeted TB prevention screening.MethodsThe Tuberculosis Network European Trials group collected, by cross-sectional survey, numbers of foreign-born TB patients residing in European Union (EU) countries, Iceland, Norway, Switzerland and the United Kingdom (UK) in 2020 from the 10 highest ranked countries of origin in terms of TB cases in each country of residence. Tuberculosis incidence rates (IRs) in countries of residence were compared with countries of origin.ResultsData on 9,116 foreign-born TB patients in 30 countries of residence were collected. Main countries of origin were Eritrea, India, Pakistan, Morocco, Romania and Somalia. Tuberculosis IRs were highest in patients of Eritrean and Somali origin in Greece and Malta (both > 1,000/100,000) and lowest among Ukrainian patients in Poland (3.6/100,000). They were mainly lower in countries of residence than countries of origin. However, IRs among Eritreans and Somalis in Greece and Malta were five times higher than in Eritrea and Somalia. Similarly, IRs among Eritreans in Germany, the Netherlands and the UK were four times higher than in Eritrea.ConclusionsCountry of origin TB IR is an insufficient indicator when targeting foreign-born populations for active case finding or TB prevention policies in the countries covered here. Elimination strategies should be informed by regularly collected country-specific data to address rapidly changing epidemiology and associated risks.
欧洲特定的结核病（TB）消除政策需要确定从 TB 筛查中受益的关键人群。
我们旨在确定居住在欧洲国家的外国出生人群，这些人群最受益于针对 TB 预防筛查的目标人群。
结核病网络欧洲试验组通过横断面调查，从每个居住国病例排名前 10 的原籍国中，收集了 2020 年居住在欧盟（EU）国家、冰岛、挪威、瑞士和英国（UK）的外国出生 TB 患者数量。比较了居住国和原籍国的 TB 发病率（IR）。
共收集了 30 个居住国的 9116 名外国出生 TB 患者的数据。主要原籍国是厄立特里亚、印度、巴基斯坦、摩洛哥、罗马尼亚和索马里。希腊和马耳他的厄立特里亚和索马里裔 TB 患者的 IR 最高（均超过 1000/100,000），波兰乌克兰裔患者的 IR 最低（3.6/100,000）。与原籍国相比，这些患者在居住国的 IR 主要较低。然而，希腊和马耳他的厄立特里亚和索马里裔患者的 IR 是原籍国的五倍。同样，德国、荷兰和英国的厄立特里亚裔患者的 IR 是原籍国的四倍。
当针对这里涵盖的国家的外国出生人群进行主动病例发现或 TB 预防政策时，原籍国的 TB IR 是一个不足够的指标。消除策略应根据定期收集的特定国家数据来制定，以应对迅速变化的流行病学和相关风险。
